S-烃基-1-烃基-3-[4-(苯并噻唑-2-巯基)苯基]异硫脲的合成及生物活性

以2-巯基苯并噻唑(1)为原料,经缩合和还原得到2-(4-氨基苯硫基)苯并噻唑(3),再与异硫氰酸苯甲酰酯或异硫氰酸烃基酯反应得到取代硫脲(5和7),最后与卤代烃反应得到20个新的S-烃基-1-烃基-3-[4-(苯并噻唑-2-巯基)苯基]异硫脲化合物(6和8),其结构经IR,1H NMR,MS及元素分析确证.初步的药理试验表明,20个目标化合物均有不同程度的iNOS抑制活性,化合物8a,8b,8c,8e,8f,8i,8j和8k的iNOS抑制活性强于阳性对照药氨基胍,其中化合物8j的iNOS抑制活性比氨基胍强26倍多.     

S-烃基-1-烃基-3-[4-(5-取代苯并咪唑-2-巯基)苯基]异硫脲的合成及生物活性

以 5 甲氧基 (或氯 ) 2 巯基苯并咪唑 ( 1)为原料 ,经缩合和还原得到 5 甲氧基 (或氯 ) 2 ( 4 氨基苯硫基 )苯并咪唑 ( 3 ) ,再与异硫氰酸烃基酯反应得到取代硫脲 4,最后与卤代烃反应得到 12个新的S 烃基 1 烃基 3 [4 ( 5 甲氧基 (或氯 )苯并咪唑 2 巯基 )苯基 ]异硫脲化合物 5 .其结构经IR ,1 HNMR ,MS及元素分析确证 .初步的药理试验表明 ,12个目标化合物的iNOS抑制活性均强于阳性对照药氨基胍     

微波辐射下合成2-芳甲酰氨基-5-(2-三氟甲基苯并咪唑-1- 亚甲基)-1,3,4-噻二唑

微波辐射下, 1-肼羰亚甲基-2-三氟甲基苯并咪唑与芳酰基异硫氰酸酯反应合成了1-(2-三氟甲基苯并咪唑-1-乙酰基)-4-芳酰基氨基硫脲(1a～1j), 继而在乙酸中合环得到了一系列的2-芳甲酰氨基-5-(2-三氟甲基苯并咪唑-1-亚甲基)-1,3,4-噻二唑(2a～2j), 反应时间短, 产率高, 副反应少. 标题化合物经元素分析, IR, 1H NMR确证结构.     

含2-三氟甲基苯并咪唑的1,3,4-噻二唑的合成

2-三氟甲基苯并咪唑-1-乙酰肼在无水乙醇中与芳基异硫氰酸酯反应得到相应的酰氨基硫脲(Ⅲa~Ⅲd)。再于室温条件下,与浓硫酸反应4h,制得2-(2-三氟甲基苯并咪唑-1--亚甲基)-5-芳氨基-1,3,4-噻二唑(Ⅳa~Ⅳd)。目标化合物经元素分析、IR和1HNMR进行了结构确证。     

1-芳酰基-4-取代吡唑甲酰基氨基硫脲和环化产物的合成及生物活性

利用1-苯基-3-甲基-5-氯-4-吡唑甲酰基异硫氰酸酯(Ⅰ)与芳酰肼(Ⅱ)的加成反应合成了系列新的酰胺基硫脲衍生物(Ⅲ),并将Ⅲ在酸性条件下进行环化反应得到2-取代吡唑甲酰基氨基-5-芳基-1,3,4-噻二唑(Ⅳ).生物活性测定结果表明部分化合物Ⅲ和Ⅳ具有较好的除草活性.     

新型胍基葡萄糖苷的合成及生物活性

将2,3,4,6-四-O-乙酰基-β-D-吡喃葡萄糖基异硫氰酸酯(1)与2-氨基-4/6-取代-苯并噻唑(2a~2e)反应, 生成糖基硫脲衍生物(3a~3e), 再在伯胺存在下经氯化汞脱硫, 得到一系列新的多乙酰基胍基糖苷类化合物(4a~4d, 5a~5d, 6a~6d, 7a~7d), 糖基的保护基团在甲醇钠/甲醇条件下脱除. 所有新化合物的结构均经IR, 1H NMR, MS谱和元素分析证实, 所得产物均为β-构型. 生物活性测试结果表明, 化合物4c, 6c, 8b, 8c等对HIV-1蛋白酶表现出了较高的抑制活性; 化合物7c具有抗流感乙型病毒活性; 化合物5e, 7c, 7d等对血管紧张素转化酶具有抑制活性.     

3-烷基/芳基-6-(1'-N-β-D-或-α-L-吡喃型全乙酰化糖基)- 均三唑并[3,4-b]-1,3,4-噻二唑的合成

通过2,3,4,6-四-O-乙酰基-β-D-吡喃型葡萄糖异硫氰酸酯(3)和2,3,4-三-O-乙酰基-α-L-吡喃型鼠李糖异硫氰酸酯(4)与3-烷基/芳基-4-氨基-5-巯基-1,2,4-三唑(5)在乙醇中回流,缩合得到了14个新的3-烷基/芳基-6-(1'-N-2',3',4',6'-四-O-乙酰基-β-D-吡喃型葡萄糖基或2',3',4'-三-O-乙酰基-α-L-吡喃型鼠李糖基)-均三唑并[3,4-b]-1,3,4-噻二唑类化合物(6a-6i,7a-7e),化合物结构经元素分析、IR和1H NMR确证.     

新型含2,4-咪唑啉二酮的4-甲基-3-苯基-2-酰亚胺噻唑啉的合成及生物活性

通过酰氯制备异硫氰酸酯,与5-(4-氨基苄基)-2,4-咪唑啉二酮反应合成了含2,4-咪唑啉二酮的N-苯甲酰基-N'-苯基硫脲,然后在三乙胺存在下再与溴丙酮发生碱催化缩合反应以中等以上收率合成了新型含2,4-咪唑啉二酮的4-甲基-3-苯基-2-酰亚胺噻唑啉,它们的化学结构经1H NMR,IR,HR-ESI-MS和化合物3g和4g的X-ray单晶衍射表征,硫脲与溴丙酮的反应机理通过化合物3g和4g的晶体结构得到进一步确证.初步生物活性测定结果表明:部分目标化合物对供试昆虫及菌种显现出良好的抑制活性,如在200 mg/L浓度下化合物3i和4q对小菜蛾的死亡率分别为86%和100%,在50 mg/L浓度下化合物4n对油菜菌核菌的抑制率为82.6%,而它们对油菜和稗草显示出微弱但并不特征的除草活性.     

N-(取代苯氧乙酰基)-N'-(4-苯基噻唑-2-基)硫脲的合成

以取代苯酚和氯乙酸为原料,合成取代苯氧乙酸,然后经过酰氯化,酯化得到取代苯氧乙酰基异硫氰酸酯,再和2-氨基-4-苯基噻唑反应得到4种N-(取代苯氧乙酰基)-N'-(4-苯基噻唑-2-基)硫脲类化合物,其中3种化合物为首次报道。化合物结构经1H NMR、IR和元素分析得到确证。初步室内生测结果表明该类化合物具有一定的抑菌活性。     

N-[5-(对三氟甲基苯基)-1,3,4-噻二唑-2-基]-N′-芳氧乙酰基硫脲的合成与生物活性

2-氨基-5-(对三氟甲基苯基)-1,3,4-噻二唑与芳氧乙酰基异硫氰酸酯反应,合成了10种新的芳氧乙酰基硫脲。其结构经1H NMR,IR和元素分析确证。初步的生物活性实验结果表明,部分化合物具有较好的植物生长调节活性。     

Synthesis of 2-alkyl(aralkyl)sulfanyl-6-methylpyrimidin-4(3<Emphasis Type="Italic">H</Emphasis>)-ones and 4-alkyl(aralkyl)oxy-2-alkyl(aralkyl)sulfanyl-6-methylpyrimidines

2-Alkyl(aralkyl)sulfanyl-6-methylpyrimidin-4(3H)-ones and 4-alkyl(aralkyl)oxy-2-alkyl(aralkyl)-sulfanyl-6-methylpyrimidines having similar or different substituents on the sulfur and oxygen atoms were synthesized by alkylation of sodium salts derived from 6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidin-4-one and 2-alkyl(aralkyl)sulfanyl-6-methylpyrimidin-4(3H)-ones with alkyl (propyl, ethyl, allyl) and aralkyl [benzyl, m-phenoxybenzyl, p-(1-adamantylbenzyl)] halides. The effects of the alkyl (aralkyl) halide nature and solvent polarity on the rate of nucleophilic substitution and product yield were studied.     

Condensed 1,2,4-Triazines I: Behaviour of Phenanthro[9,10-e]-1,2,4-triazine Derivatives Towards Alkylating and Reducing Agends,Grignard Reagents,and Amines

Alkylation of 3-hydroxy-phenanthro[9,10-e]1,2,4-triazine ( 1a ) yielded the N(2)-alkyl derivatives 2a – 2b ; alkylation of the 3-mercapto analogue 1b yielded the S-alkyl derivatives 1f – 1i . 1a – 1b reacted with alkyl and aralkylmagnesium halides to yield the corresponding 3-hydroxy-, and 3-mercapto-5-alkyl-(aralkyl)-phenanthro[9,10-e]2,3,4,5-tetrahydro-1,2,4-triazines 5a – 5f . Reduction of 1a yielded the hexahydrotriazine derivative 7 . Amination of 1c yielded the 3-amino derivatives 1j – 1o after prolonged heating.     

Convenient method for the synthesis of some novel chiral methyl 2-(2-oxo-2H-benzo[e][1,3]oxazin-3(4H)-yl)propanoate derivatives and biological evaluation of their antioxidant,cytotoxic, and molecular docking properties

Ten chiral methyl 2-(2-oxo-2H-benzo[e][1,3]oxazin-3(4H)-yl)propanoate derivatives 6a-6j have been synthesized from optically pure amino methyl phenol 5 and 4-nitrophenyl chloroformate. These derivatives 6a-6j are characterized by ¹H NMR, ¹³C NMR, FT-IR, and HRMS spectral techniques. Optical purity of these derivatives was confirmed by chiral HPLC method. Ten synthesized ester derivatives 6a-6j were screened for their in vitro antioxidant activity. Among the compounds 6b-d and 6h-j have exhibited comparable antioxidant activity with ascorbic acid as a standard. Compounds 6a and 6e-g have shown moderate antioxidant activity. Further, the in vitro cytotoxicity of these compounds were studied through MTT cell proliferation assay in addition the effect on LDH leakage and NO release. Among the derivatives, 6j showed extremely best activity and the IC₅₀ value (12.54 ± 0.71 μM) is very close to doxorubicin (7.2 ± 0.58 μM) as a standard. Compounds 6b , 6h , and 6i showed better inhibition next to compound 6j on the viability of HepG2 cells with an IC₅₀ value (μM) of 56.02 ± 1.4, 41.76 ± 0.58, and 38.17 ± 0.34, respectively. Also, molecular docking studies have been carried out with STAT-3 (PDB ID: 1BG1) and BCL-2 (PDB ID: 4AQ3) proteins against the four active compounds 6b , 6h , 6i , and 6j . The binding energies of the tested compounds were in the range of −7.76 to −8.41 kcal/mol, which is very close to doxorubicin (−8.53 kcal/mol) as a standard. These molecular docking results are in good agreement with the in vitro studies.     

The synthesis of 2-chloro-1-(β-D-ribofuranosyl)benzimidazole and certain related derivatives

The synthesis of 2-chloro-1-(β-D-ribofuranosyl)benzimidazole (4b) has been accomplished by a condensation of 2-chloro-1-trimethylsilylbenzimidazole (1) with 2,3,5-tri-O-acetyl-D-ribofuranosyl bromide (2) followed by subsequent deacetylation. Nucleophilic displacement of the 2-chloro group has furnished several interesting 2-substituted-1-(β-D-ribofuranosyl)benzimidazoles. 1-(β-D-Ribofuranosyl)benzimidazole (5) and 1-(β-D-ribofuranosyl)benzimidazole-2-thione (6) were prepared from 4b and 6 was also prepared by condensation of 2 with silylated benzimidazole- 2-thione (3). Alkylation of 6 furnished certain 2-alkylthio-1-(β-D-ribofuranosyl)benzimidazoles and oxidation of 6 with alkaline hydrogen peroxide produced 1-(β-D-ribofuranosyl)benzimidazole-2-one (9). The assignment of anomeric configuration for all nucleosides reported is discussed.     

Synthesis,spectral characterization,and antituberculosis activity of thiazino[3,2-A]benzimidazole derivatives

A series of novel thiazino[3,2-a]benzimidazole derivatives synthesized by cyclization of (R)-2-(chloromethyl)oxirane with benzimidazole-2-thiol followed by reacted with benzyl bromides in high yield under milder conditions. The molecular structures of all compounds were confirmed by ¹H and ¹³C NMR spectroscopy and Mass spectrometry. The absolute configuration of the compounds was confirmed by X-ray diffraction analysis. All the synthesized compounds were evaluated in vitro for their antituberculosis activity.     

4-（4′-甲氧基-苯基）亚甲基-1h-咪唑啉-5-酮类schiff碱的合成与生物活性

咪唑啉酮;schiff碱;串联aza-wittig反应;合成;生物活性     

Synthesis of bis-3-alkyl-5-arylhydantoins and bis-3-alkyl-5-arylthiohydantoins separated by two and four carbon atoms

Synthesis of 1,2- and 1,4-bis-thiohydantoins and hydantoins employing ethylenediamine and 1,4-diaminobutane as spacers is described. Compounds containing a two carbon bridge were synthesized by alkylation of ethylenediamine with two equivalents of N-t-butyl-α-(p-toluenesulfonyloxy)phenylacetamide 3 . The phenyl isothiocyanate adduct of 3 cyclized in refluxing toluene to form 1a . Other isothiocyanate or isocyanate adducts derived from alkylation product 4 required hydrolysis to induce cyclization. Compounds 1b-1f were obtained in this way. Compounds with a four carbon bridge were obtained by reaction of two equivalents of methyl α-bromophenyl acetate and 1,4-diaminobutane to produce N,N'-bis-[(α-phenyl-α-methoxycarbonyl)methyl]butylenediamine 6 . The isothiocyanate or isocyanate adducts from 6 cyclized, without hydrolysis, to form compounds 2a-2e .     

SYNTHESIS OF 3-(2-MERCAPTO-4-THIAZOLYL)-2H-1-BENZOPYRAN-2-ONE AND ITS DERIVATIVES

Abstract

Treatment of 3-(2-bromoacetyl)coumarins with ammonium dithiocarbamate provides 3-2-mercapto-4-thiazolyl)-2H-1-benzopyran-2-one (11) but not 4-hydroxy-4-(3-coumaririnyl) thiazolidine-2-thione (I). II undergoes smooth condensation with alkyl, aralkyl, phenacyl and acid halides to give corresponding thioethers and thioesters (III) respectively. The structures of the newly synthesized compounds were established on the basis of spectral data (IR, PMR and MS).     

The first Cu(I)-mediated nucleophilic trifluoromethylation reactions using (trifluoromethyl)trimethylsilane in ionic liquids

The new ionic liquids (5a-8a) were used as reaction media for nucleophilic trifluoromethylation reactions of trifluoromethyl(trimethyl)silane with (1) aryl, allyl, benzyl, and alkyl halides in Cu(I)-mediated C-C bond formation reactions, and (2) carbonyl functionalities catalyzed with Ph3P or CsF. In addition, conversion of benzyl bromide as a model compound to benzyl fluoride was examined in using 6a CsF as the fluorinating reagent. The morpholinium-based ionic liquid (6a) stood out as an efficient solvent system comparable to organic solvents and superior to the other new ionic liquids prepared in this work as well as to [bmim]+[PF6]-. Neat reactions of N-methyloxazolidine (1), N-methylmorpholine (2), N-methylimidazole (3) or N-methyltriazole (4) with 2-(2-ethoxyethoxy)ethyl bromide (BrCH2CH2OCH2CH2OCH2CH3, ) or 2-bromoethyl methyl ether (BrCH2CH2OCH3, 10) at 75 or 105 degrees C gave the N-(2-ethoxyethoxy)ethyl- or N-methoxyethyl-substituted oxazolidinium, morpholinium, imidazolium and triazolium quaternary bromides (1a-4a, 1b-4b) which were metathesized with LiN(SO2CF3)2 to form the respective room-temperature liquid bis(trifluoromethanesulfonyl)amides 5a-8a and 5b-8b in high yields with transition or melting points < -78 degrees C as determined by DSC. All of the ionic liquids are thermally stable to > 310 degrees C as determined by thermogravimetric analyses (TGA). Densities range between 1.29 and 1.53 g cm(-3) at 25 degrees C.     

N-取代苄基-3,5-双苄叉基-哌啶-4-酮的合成及其抗癌活性的测定

以取代苄胺或伯胺为原料,依次经过Michael加成、Dieckmann缩合、水解脱羧和羟醛缩合反应,合成了10种新化合物(8a～8j),目标化合物的结构经1H NMR、IR、MS和元素分析确证。 初步的MTT法生物活性测试表明,目标化合物在100 mg/L浓度下能有效抑制白血病K562细胞、乳腺癌HO8910PM细胞和卵巢癌MDR-MB-231细胞的增殖,具有潜在的抗癌活性。